SCHEMBL2856718

SCHEMBL2856718

CC(=CC(=O)Cl)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2856716 1.00
SCHEMBL1960558 1.00
SCHEMBL3394884 0.79
SCHEMBL7993176 0.79
SCHEMBL9505140 0.77
SCHEMBL12831741 0.77
SCHEMBL19451627 0.77
SCHEMBL248833 0.73
SCHEMBL10717619 0.73
SCHEMBL250153 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10626076-B2 Process for the synthesis of dimethyl fumarate BIOPHORE INDIA PHARMAEUTICALS PVT. LTD. (IN) 2020-04-21 US claimed
EP-0541966-A2 Process for preparing amide derivatives from halomines and acid halides AMERICAN CYANAMID COMPANY (US) 1993-05-19 EP claimed
US-4299911-A POLYMER CONTAINING AN ETHYLENICALLY UNSATURATED DOUBLE BOND SOMAR MANUFACTURING CO., LTD. (JP) 1981-11-10 US claimed
EP-4230264-B1 PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DESEASES ALKERMES PHARMA IRELAND LTD (IE) 2026-01-28 EP disclosed
US-20260001890-A1 Prodrugs of Fumarates and Their Use in Treating Various Diseases ALKERMES PHARMA IRELAND LTD (IE) 2026-01-01 US disclosed
EP-2970101-B2 PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DESEASES ALKERMES PHARMA IRELAND LTD (IE) 2025-09-03 EP disclosed
US-20250127747-A1 Prodrugs of Fumarates and Their Use in Treating Various Diseases JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2025-04-24 US disclosed
US-20250057770-A1 Monomethylfumarate Prodrug Compositions JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2025-02-20 US disclosed
US-20240300969-A1 Prodrugs of Fumarates and Their Use in Treating Various Diseases ALKERMES PHARMA IRELAND LTD (IE) 2024-09-12 US disclosed
US-12076306-B2 Prodrugs of fumarates and their use in treating various diseases ALKERMES PHARMA IRELAND LIMITED (IE) 2024-09-03 US disclosed
US-11905298-B2 Prodrugs of fumarates and their use in treating various diseases ALKERMES PHARMA IRELAND LIMITED (IE) 2024-02-20 US disclosed
EP-2186819-A1 Novel glucopyranose esters and glucofuranose esters of alkyl- fumarates and their pharmaceutical use Aditech Pharma AG (CH) 2010-05-19 EP disclosed
EP-1915387-B1 NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FUMARATES AND THEIR PHARMACEUTICAL USE ADITECH PHARMA AG (CH) 2010-01-20 EP disclosed
EP-1915387-A1 NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FUMARATES AND THEIR PHARMACEUTICAL USE Aditech Pharma AB (SE) 2008-04-30 EP disclosed
WO-2007006308-A1 NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FU MARATES AND THEIR PHARMACEUTICAL USE ADITECH PHARMA AB (SE) 2007-01-18 WO disclosed
EP-0735056-B1 Catalyst for the polymerization of olefines and processes for the polymerization of olefines using the same TONEN CORP (JP) 1998-06-10 EP disclosed
US-5747595-A TRIALKOXYALKYLSILANE TONEN CORPORATION (JP) 1998-05-05 US disclosed
EP-0735056-A1 Catalyst for the polymerization of olefines and processes for the polymerization of olefines using the same Tonen Corporation (JP) 1996-10-02 EP disclosed
EP-0541966-A2 Process for preparing amide derivatives from halomines and acid halides AMERICAN CYANAMID COMPANY (US) 1993-05-19 EP disclosed
US-4299911-A POLYMER CONTAINING AN ETHYLENICALLY UNSATURATED DOUBLE BOND SOMAR MANUFACTURING CO., LTD. (JP) 1981-11-10 US disclosed